PTGS2 and cancer: It is therefore unlikely that the inhibition of ACSL4-stimulated COX-2 expression by AA861 reported here may be due to an activation of apoptosis or inhibition of cell growth or survival since the inhibition of COX-2 expression is evident at least 48 h earlier than the inhibition in cell proliferation described for different cancer cell lines.